Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes (Q35894040)

11 August 2017

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes (English)

1 reference

triple-negative breast cancer

11 August 2017

0 references

Sharon H Giordano

5

0 references

Funda Meric-Bernstam

6

object named as

Funda Meric-Bernstam

1 reference

11 August 2017

Ana Maria Gonzalez-Angulo

12

object named as

Ana Maria Gonzalez-Angulo

1 reference

11 August 2017

11

Gabriel N Hortobagyi

1 reference

11 August 2017

Shaheenah Dawood

1

1 reference

11 August 2017

Kristine Broglio

2

1 reference

11 August 2017

Shu-Wan Kau

3

1 reference

11 August 2017

Marjorie C Green

4

1 reference

11 August 2017

Thomas A Buchholz

7

1 reference

11 August 2017

Constance Albarracin

8

1 reference

11 August 2017

Wei T Yang

9

1 reference

11 August 2017

Bryan T J Hennessy

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Journal of Clinical Oncology

11 August 2017

1 reference

11 August 2017

27

1 reference

11 August 2017

2

1 reference

11 August 2017

220-226

1 reference

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Effect of screening and adjuvant therapy on mortality from breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Repeated observation of breast tumor subtypes in independent gene expression data sets

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Tumor characteristics in African American and white women

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Molecular portraits of human breast tumours

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Race, socioeconomic status, and breast cancer treatment and survival

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

The relation between health insurance coverage and clinical outcomes among women with breast cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516695

Black/white differences in type of initial breast cancer treatment and implications for survival

24 September 2018

1 reference

12 December 2020

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience

1 reference

12 December 2020

The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization

1 reference

12 December 2020

Ethnicity and breast cancer: factors influencing differences in incidence and outcome

1 reference

12 December 2020

Nuclear structure in cancer tissues

1 reference

12 December 2020

African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy

1 reference

12 December 2020

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.17.9952

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

19047281

1 reference